Streetbeat News

Stock Prices

NBY

NovaBay Pharmaceuticals' shares rose following the announcement of a definitive agreement to sell its Avenova assets for $9.5 million.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:13 pm

AAPL

DJT

FDX

LOT

LUNR

MADE

NVDA

QQQ

TSLA

WAY

The article lists the top 10 trending stocks on WallStreetBets as of September 20, 2024, according to Swaggy Stocks. The stocks mentioned include NVDA, LUNR, MADE, WAY, TSLA, DJT, FDX, LOT, QQQ, and AAPL.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:12 pm

ZONE

CleanCore Solutions' shares are trading higher following the release of their full-year fiscal 2024 results.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:09 pm

NVDA

NVO

TSLA

The European Drug Agency has backed Novo Nordisk's Wegovy for obesity-related heart failure, while Bitcoin's correction ends with a target to reach $70K. Nvidia and Tesla rally as the Dow and S&P 500 hit new highs after Fed rate cuts.

Portfolio Pulse from Akanksha Bakshi

September 20, 2024 | 1:04 pm

NKE

Nike appoints Elliott Hill as new CEO to repair retailer relations and boost sales. The leadership change follows a 25% drop in Nike's shares this year. Hill's appointment led to a 6% surge in premarket trading, indicating investor optimism.

Portfolio Pulse from Benzinga Neuro

September 20, 2024 | 1:03 pm

SRBK

SR Bancorp has announced a share repurchase program, allowing the company to buy back up to 950,793 shares. This move is often seen as a way to return value to shareholders and can indicate that the company believes its stock is undervalued.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:03 pm

INTU

Spruce Point Capital has issued a strong sell opinion on Intuit, citing concerns over lack of transparency and competitive threats. They predict a long-term downside of 40%-80% for the company.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:01 pm

NLY

Annaly Capital Management (NYSE:NLY) has received mixed analyst ratings, with recent upgrades in price targets. Despite a negative revenue trend and low profitability metrics, analysts have raised their price targets, indicating potential optimism. The company's debt management is seen positively.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 1:00 pm

CFLT

Confluent (NASDAQ:CFLT) has been the subject of analysis by 22 analysts over the past three months, with opinions ranging from bullish to bearish. The average 12-month price target has decreased from $34.75 to $29.95. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Confluent's financial performance shows strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 1:00 pm

WHLRL

The trading halt status was updated at 9:00 AM ET, indicating a resumption of quotations. This update may involve WHLRL, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:00 pm